Table 1 The clinical and pathological characteristics of 54 patients with and without lymphatic metastasis
| Â | Unmetastatic | Metastatic | P value |
|---|---|---|---|
No | 29 | 25 | – |
Age (years) | 63.93 ± 6.92 | 59.40 ± 10.72 | 0.067 |
BMI (kg/m2) | 24.35 ± 3.22 | 23.13 ± 4.25 | 0.830 |
Inpatient days | 25.41 ± 4.656 | 16.08 ± 6.22 | 0.655 |
Tumor size (cm) | 2.39 ± 1.04 | 4.19 ± 2.83 | 0.002** |
Sex | |||
 Males | 18 (62.07%) | 17 (68.00%) | 0.649 |
 Females | 11 (37.93%) | 8 (32.00%) | |
Tumor location | |||
 Fundus | 4 (14.29%) | 6 (24.00%) | 0.320 |
 Body | 12 (42.86%) | 13 (52.00%) | |
 Antrum | 12 (42.86%) | 6 (24.00%) | |
Differentiation | |||
 Well | 2 (6.90%) | 1 (4.00%) | 0.047* |
 Moderate | 10 (34.48%) | 2 (8.00%) | |
 Moderate to Poor | 10 (34.48%) | 8 (32.00%) | |
 Poor | 7 (24.14%) | 14 (56.00%) | |
Lauren type | |||
 Intestinal-type | 12 (52.17%) | 6 (26.09%) | 0.102 |
 Diffuse | 4 (17.40%) | 10 (43.48%) | |
 Mixed-type | 7 (30.43%) | 7 (30.43%) | |
T stage | |||
 1 | 16 (55.17%) | 0 (0.00%) | < 0.001*** |
 2 | 8 (27.59%) | 13 (52.00%) | |
 3 | 3 (10.34%) | 8 (32.00%) | |
 4 | 2 (6.90%) | 4 (16.00%) | |
N stage | |||
 0 | 29 (100%) | 0 (0.00%) | < 0.001*** |
 1 | 0 (0.00%) | 9 (36.00%) | |
 2 | 0 (0.00%) | 5 (20.00%) | |
 3 | 0 (0.00%) | 11 (44.00%) | |
M stage | |||
 0 | 29 (100%) | 25 (100%) | – |
 1 | 0 (0.00%) | 0 (0.00%) | |